Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Mediators of Inflammation
Volume 2016, Article ID 1405924, 10 pages
http://dx.doi.org/10.1155/2016/1405924
Research Article

Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice

1Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
2Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
3Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China

Received 23 October 2015; Accepted 20 December 2015

Academic Editor: Hannes Neuwirt

Copyright © 2016 Xiao-Wen Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Xiao-Wen Chen, Xiao-Yan Du, Yu-Xian Wang, et al., “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice,” Mediators of Inflammation, vol. 2016, Article ID 1405924, 10 pages, 2016. https://doi.org/10.1155/2016/1405924.